Marin Bulic

Medical Representative

Croatia

Connect with Marin Bulic to Send Message

Connect

Connect with Marin Bulic to Send Message

Connect

Timeline
About me
First Line Sales Manager Cardiovascular, Renal and Metabolic at AstraZeneca
Education
- Faculty of Veterinary medicine Zagreb
  2000 - 2007
  Doctor of Veterinary Medicine
- Zagreb School of Economics and Management
  2018 - 2022
  Master of Business Administration - MBA Excellent
Experience
- Solvay Pharmaceuticals
  Mar 2008 - Oct 2009
  Medical Representative
  Medical Representative for cardiovascular portfolio
- Solvay Pharmaceuticals (Abbot Products from Feb 2010)
  Oct 2009 - Jan 2011
  Regional Project Coordinator
  Project implementation for cardiovascular portfolioSupport for the Residual Risk Reduction InitiativeCoordination of medical representativesWeb editor for cardiovascular portfolio
- Abbott Labboratories
  Jan 2011 - Sept 2015
  Medical Representative
  Medical Representative for cardiovascular, CNS, Pain and Gynaecology portfolioMedical consulting of physicians in Bosnia and HerzegovinaEditor of journal “Cardionicle”
- Mylan
  Sept 2015 - Sept 2016
  Medical Representative
  Medical Representative for CNS, Pain and Gynaecology portfolioEditor of journal “Cardionicle”
- Takeda
  Sept 2016 - Jan 2022
  - KAM & Oncology Lead - Croatia
    Jun 2019 - Jan 2022
  - Marketing & Key Accounts Manager Oncology Croatia
    Jan 2019 - Jun 2019
  - Key Account Manager Oncology and Hospital
    Sept 2016 - Jan 2019
- AstraZeneca
  Jan 2022 - now
  Responsible for achieving sales objectives for Forxiga and Xigduo through effective and efficient leadership, motivation, and management of the Sales Department (Medical Representatives) in Croatia. Development and implementation of both strategic and tactical marketing plans for Calquence across Bulgaria, Croatia, Montenegro, Slovenia, and Serbia. Successful launch of Calquence in Slovenia, Croatia, and Bulgaria, as well as ensuring pre-launch activities in Serbia and Montenegro, significantly surpassing ambitious targets.
  - First Line Sales Manager Cardiovascular, Renal and Metabolic
    Mar 2024 - now
  - Brand Manager Haematology Balkans (BGR, HRV, MNE, SRB, SVN)
    Nov 2022 - Feb 2024
  - FB Brand Manager Haematology Balkans
    Jan 2022 - Nov 2022
Licenses & Certifications
- C1 Advanced English Certificate
  Foreign Languages Centre Vodnikova
  Feb 2017
Honors & Awards
- Awarded to Marin Bulic
  WeCelebrate global recognition platform - BRONZE AWARD, INNOVATION - recognized by Igor Prebilić, Senior Medical Advisor Oncology & Hematology HRV - Mar 2021 "Marin has started a series of meetings between experienced KOLs and practicing clinicians, based on dilemmas in clinical practice - related to the use of Takeda products in lymphoma and multiple myeloma. These meetings have become a platform for discussing best therapeutic solutions for patients with high unmet needs, providing education to younger physicians attending and actively participating in the polls and case reviews."
- Awarded to Marin Bulic
  WeCelebrate global recognition platform - BRONZE AWARD, DELIVERING RESULTS – recognized by Barbara Markovič, Commercial and Launch Excellence Lead TAKEDA Feb 2021 “Thank you Marin for your energy, enthusiasm, knowledge and professionality! The MCE plan that you created shown high level understanding of landscape, customer profile, journey and needs reflecting in tactics identification, content development and channels selection. Plan will serve as great base and example on how to build customer-centric MCE plan using the Takeda MCE planning process. Thank you for driving this process and sharing project practice among other colleagues and countries.”
- Awarded to Marin Bulic
  WeCelebrate global recognition platform - SILVER AWARD, INNOVATION – recognized by Ena Vitlov, Commercial Head Oncology and Hematology Croatia and Slovenia TAKEDA Jan 2021 “Brilliant and innovative multichannel solutions primarily organized and executed by Marin had a significant positive impact on Takeda oncology business & Takeda reputation during COVID-19 pandemic (FY 2020). Many of the solutions were recognized on Multi-Country Organization and Europe-Canada level and even outside of oncology business unit (Clinical dilemmas, Takeda moment).”
- Awarded to Marin Bulic
  Recognize AWARD Takeda MCO Eastern Europe Apr 2020 “…for extraordinary performance and team work in FY 2019, innovation and drive for results throughout FY 2019 that resulted with great activities and excelled Ninlaro sales. Person that was one of the most important contributors to this growth was Marin.”
- Awarded to Marin Bulic
  Recognize AWARD Takeda MCO Eastern Europe Dec 2019 “…for going an extra mile in driving the execution of the innovative Takeda organized event. "From theory to practice" was totally new workshop concept developed and executed by Croatian cross-functional Oncology team that increased Takeda reputation in hematologist community on a next level providing them time, topics and concept that facilitated scientific opinion exchange and establishing professional relationships. Marin was project lead.”
- Awarded to Marin Bulic
  Recognition for commitment, teamwork and excellence in achieving and surpassing financial and growth targets in FY17 ADCETRIS IBT Apr 2018
- Awarded to Marin Bulic
  Awarded with Chrones award for contribution in publishing of Cardionicle - 2015 The project initiator and editor of Cardionicle journal
- Awarded to Marin Bulic
  Awarded with Apollo award in recognition for outstanding achievements - 2013
- Awarded to Marin Bulic
  Awarded for the best sales results for Olicard - 2010
- Awarded to Marin Bulic
  Awarded for the best non-marketing innovation - 2009
- Awarded to Marin Bulic
  Awarded for the best team result - 2009
- Awarded to Marin Bulic
  Awarded for the best region - 2008